查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1318038

肝素市場：按產品類型、給藥途徑、用途和最終用戶分類 - 全球預測 2023-2030

Heparin Market by Product Type, Route of Administration, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球肝素市場將達78.503億美元，複合年複合成長率為11.12%，預計2030年將達到164.9824億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球肝素市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 肝素的全球市場規模和預測是多少？

2.在預測期內，COVID-19對全球肝素市場的阻礙因素與影響為何？

3. 在預測期內，全球肝素市場需要投資哪些產品/細分市場/應用/領域？

4.肝素在全球市場的競爭策略為何？

5. 全球肝素市場的技術趨勢和法律規範是什麼？

6.全球肝素市場主要供應商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球肝素市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 靜脈血栓栓塞症和心血管疾病增加
      • 抗凝血劑需求量大
      • 深層靜脈栓塞症(DVT) 發生率增加
    • 抑制因素
      • 與肝素相關的副作用
    • 機會
      • 肝素藥物改良以開發新藥合成藥物開發為重點
      • 增加醫療費用並提高患者意識
    • 任務
      • 生豬供應問題
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 肝素市場：依產品類型

  • 低分子肝素
  • 超低分子肝素
  • 普通肝素

第7章 肝素市場：依給藥途徑分類

  • 靜脈注射
  • 皮下注射

第8章 肝素市場：依用途

  • 臨床試驗
  • 疾病治療
  • 醫用器材

第9章 肝素市場：依最終使用者分類

  • 血液/幹細胞庫
  • 醫院

第10章 美洲肝素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太肝素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲肝素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-43127F7278DE

The Global Heparin Market is forecasted to grow significantly, with a projected USD 7,850.30 million in 2023 at a CAGR of 11.12% and expected to reach a staggering USD 16,498.24 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Heparin Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Heparin Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, and Unfractionated Heparin. The Unfractionated Heparin is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across IV Injection and Subcutaneous Injection. The IV Injection is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical trials, Disease treatment, and Medical devices. The Disease treatment is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Blood & Stem Cell Bank and Hospitals. The Blood & Stem Cell Bank is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Heparin Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Heparin Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Heparin Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Heparin Market?

4. What is the competitive strategic window for opportunities in the Global Heparin Market?

5. What are the technology trends and regulatory frameworks in the Global Heparin Market?

6. What is the market share of the leading vendors in the Global Heparin Market?

7. What modes and strategic moves are considered suitable for entering the Global Heparin Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Heparin Market, by Product Type, 2022 vs 2030
  • 4.3. Heparin Market, by Route of Administration, 2022 vs 2030
  • 4.4. Heparin Market, by Application, 2022 vs 2030
  • 4.5. Heparin Market, by End-User, 2022 vs 2030
  • 4.6. Heparin Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth in number of venous thromboembolism and cardiovascular disorders
      • 5.1.1.2. High demand for anticoagulants
      • 5.1.1.3. Rising incidences for deep vein thrombosis (DVT)
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with Heparin
    • 5.1.3. Opportunities
      • 5.1.3.1. Improved pharmaceutical focus on new drug development and development of synthetic heparin
      • 5.1.3.2. Increasing health expenditure and awareness among patients
    • 5.1.4. Challenges
      • 5.1.4.1. Porcine availability issues
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Heparin Market, by Product Type

  • 6.1. Introduction
  • 6.2. Low Molecular Weight Heparin
  • 6.3. Ultra-Low Molecular Weight Heparin
  • 6.4. Unfractionated Heparin

7. Heparin Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. IV Injection
  • 7.3. Subcutaneous Injection

8. Heparin Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical trials
  • 8.3. Disease treatment
  • 8.4. Medical devices

9. Heparin Market, by End-User

  • 9.1. Introduction
  • 9.2. Blood & Stem Cell Bank
  • 9.3. Hospitals

10. Americas Heparin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Heparin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Heparin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HEPARIN MARKET RESEARCH PROCESS
  • FIGURE 2. HEPARIN MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HEPARIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
  • FIGURE 6. HEPARIN MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. HEPARIN MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. HEPARIN MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. HEPARIN MARKET DYNAMICS
  • FIGURE 10. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. HEPARIN MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. HEPARIN MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS HEPARIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HEPARIN MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HEPARIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. HEPARIN MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. HEPARIN MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HEPARIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HEPARIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. HEPARIN MARKET SIZE, BY LOW MOLECULAR WEIGHT HEPARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. HEPARIN MARKET SIZE, BY ULTRA-LOW MOLECULAR WEIGHT HEPARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HEPARIN MARKET SIZE, BY UNFRACTIONATED HEPARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 9. HEPARIN MARKET SIZE, BY IV INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HEPARIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. HEPARIN MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. HEPARIN MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HEPARIN MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. HEPARIN MARKET SIZE, BY BLOOD & STEM CELL BANK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. HEPARIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HEPARIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. HEPARIN MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 187. HEPARIN MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 188. HEPARIN MARKET LICENSE & PRICING